CompletedPHASE2, PHASE3NCT00997815

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Siriraj Hospital
Principal Investigator
Rattapon Thoungtong, MD
Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University
Intervention
Botulinum toxin A(drug)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
20092011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00997815 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials